A SINGLE MISSENSE MUTATION IN 77% OF PROSTATE CANCER BONE METASTASES: NOVEL OPPORTUNITY FOR GENETIC BIOMARKER AND NOVEL THERAPEUTIC MITOCHONDRIAL TAR
$509,451FY2016Department of DefenseDOD
Emory University, Atlanta GA
Investigators
View source on USAspending →A SINGLE MISSENSE MUTATION IN 77% OF PROSTATE CANCER BONE METASTASES: NOVEL OPPORTUNITY FOR GENETIC BIOMARKER AND NOVEL THERAPEUTIC MITOCHONDRIAL TAR · GrantIndex